Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 237722
                    [Title] => Results of landmark heart study bared
                    [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.


Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA. 


                    [DatePublished] => 2004-02-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 133121
                    [Title] => Gamot para sa stroke
                    [Summary] => Inilunsad kamakailan ang Perindopril Protection Against Recurrent Stroke Study (PROGRESS) sa Shangri-la EDSA Plaza Hotel, Mandaluyong City. Sa paglulunsad, isang makabuluhang scientific meeting din ang naganap na may kaugnayan sa stroke prevention. Ang PROGRESS ay itinatag sa pamamagitan ng Philippine Neurological Association (PNA).


Nagsagawa ng lecture si Dr. Joven Cuanang, prominent neurologist at president ng Stroke Society of the Philippines tungkol sa rationale, design and results ng PROGRESS.


                    [DatePublished] => 2001-09-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1285088
                    [AuthorName] => Dr. Tranquilino Elicaño Jr.
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

        )

)

DR. HOMOBONO CALLEJA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 237722
                    [Title] => Results of landmark heart study bared
                    [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.


Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA. 


                    [DatePublished] => 2004-02-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 133121
                    [Title] => Gamot para sa stroke
                    [Summary] => Inilunsad kamakailan ang Perindopril Protection Against Recurrent Stroke Study (PROGRESS) sa Shangri-la EDSA Plaza Hotel, Mandaluyong City. Sa paglulunsad, isang makabuluhang scientific meeting din ang naganap na may kaugnayan sa stroke prevention. Ang PROGRESS ay itinatag sa pamamagitan ng Philippine Neurological Association (PNA).


Nagsagawa ng lecture si Dr. Joven Cuanang, prominent neurologist at president ng Stroke Society of the Philippines tungkol sa rationale, design and results ng PROGRESS.


                    [DatePublished] => 2001-09-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1285088
                    [AuthorName] => Dr. Tranquilino Elicaño Jr.
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

        )

)

abtest

Results of landmark heart study bared

February 5, 2004 - 12:00am

More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that...

Science and Environment

Gamot para sa stroke

By Dr. Tranquilino Elicaño Jr. | September 9, 2001 - 12:00am

Inilunsad kamakailan ang Perindopril Protection Against Recurrent Stroke Study (PROGRESS) sa Shangri-la EDSA Plaza Hotel, Mandaluyong City. Sa paglulunsad, isang makabuluhang scientific meeting din ang naganap na...

PSN Opinyon